Optimer Pharmaceuticals and Clinical Investigators to Present Data at Upcoming Medical Meetings
Companies:Optimer Pharmaceuticals, Inc..Related Quotes
Symbol Price Change
OPTR 12.69 -0.11
Press Release Source: Optimer Pharmaceuticals, Inc. On Thursday April 28, 2011, 8:00 am EDT
SAN DIEGO, April 28, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR - News) announced that additional data from the DIFICID™ Phase 3 trials will be presented at the following medical meetings:
Digestive Disease Week (DDW), McCormick Place, Chicago, IL
May 7-10, 2011
Poster Presentation Information:
Title:
Risk of Recurrence and Time to Recurrence Following Treatment of Clostridium
difficile Infection: Patient Characteristics and the Differential Effect of Fidaxomicin
vs. Vancomycin
Presenter:
Kathleen M. Mullane, D.O.
Date:
Saturday, May 7, 2011
Time:
12:00 p.m. to 2:00 p.m. Central Time
Location:
Poster Session Hall A (MCP)
Session:
Intestinal Disorders: Prebiotics, Probiotics and Pathogens
Program #:
Sa1981
Poster Presentation Information:
Title:
High Fecal and Low Plasma Levels of Fidaxomicin and Metabolite OP-1118 in
Patients with C. difficile infection: Combined Results of Two Phase 3 Trials
Presenter:
Pamela S. Sears, Ph.D.
Date:
Monday, May 9, 2011
Time:
12:00 p.m. to 2:00 p.m. Central Time
Location:
Poster Session Hall A (MCP)
Session:
Randomized Controlled Clinical Trials
Program #:
Mo1160
European Congress of Clinical Microbiology and Infectious Diseases and International Congress of Chemotherapy, Milano Convention Center, Milan, Italy
May 7-10, 2011
Oral Presentation Information:
Title:
Immunosuppression and the Risk of Death, Cure Rates and Disease Recurrence
Among Patients with Clostridium difficile Infection
Presenter:
Yoav Golan, M.D., M.S.
Date:
Tuesday, May 10, 2011
Time:
10:36 a.m. to 10:48 a.m. Central European Time
Location:
Lecture Hall Brown 1
Oral Session:
C. difficile News
Presentation #:
O504
Poster Presentation Information:
Title:
Clostridium difficile Recurrence, Alcohol Consumption, and the Effect of
Fidaxomicin vs. Vancomycin
Presenter:
Yoav Golan, M.D., M.S.
Date:
Tuesday, May 10, 2011
Time:
12:30 p.m. to 1:30 p.m. Central European Time
Location:
Poster Area Hall 5
Poster Topic 99:
Clostridium difficile
Poster ID#:
P1968
2011 Annual Scientific Meeting of the American Geriatrics Society (AGS), The Gaylord National Hotel, National Harbor, Maryland
May 11-14, 2011
Poster Presentation Information:
Title:
Effect of Advancing Age on Outcomes of Therapy for Clostridium difficile Infection
Presenter:
Thomas J. Louie, M.D.
Date:
Thursday, May 12, 2011
Time:
4:30 p.m. to 6:00 p.m. Eastern Time
Session:
Presidential Poster Session B
Location:
Exhibit Hall
Poster ID#:
B126
News 
Market Data 
Discover 
